Dunn Winston, Xu Ronghui, Wingard Deborah L, Rogers Christopher, Angulo Paul, Younossi Zobair M, Schwimmer Jeffrey B
Division of Gastroenterology, Department of Medicine, University of California, San Diego, La Jolla, California, USA.
Am J Gastroenterol. 2008 Sep;103(9):2263-71. doi: 10.1111/j.1572-0241.2008.02034.x. Epub 2008 Aug 5.
Case series suggest that nonalcoholic fatty liver disease (NAFLD) is associated with increased all-cause and cardiovascular mortality. The current study compared the survival of subjects with and without suspected NAFLD in a population-based cohort, and placed the finding in the context of previously published case series.
Primary analysis assessed mortality for NHANES-III participants with and without suspected NAFLD using the National Death Index. Suspected NAFLD was based upon unexplained ALT elevation. The Olmsted County and Cleveland Clinic case series were also used for comparison. Survivals were compared using Proportional Hazards Model and direct age standardization.
The NHANES cohort included 980 with and 6,594 subjects without suspected NAFLD. Over a mean of 8.7 yr, suspected NAFLD had a hazards ratio of 1.37 (95% CI 0.98-1.91) for all-cause mortality. In the 45-54 age group, suspected NAFLD had significantly higher all-cause (4.40 95% CI 1.27-13.23) and cardiovascular mortality (8.15, 95% CI 2.00-33.20) after adjusting for conventional cardiovascular risk factors. The age-standardized rate per 10,000 per year was 129 (95% CI 118-140) for the NHANES non-NAFLD cohort, 154 (95% CI 116-198) for the NHANES suspected NAFLD cohort, 214 (95% CI 157-279) for the Olmsted County series, and 426 (95% CI 298-573) for the Cleveland Clinic series.
The magnitude of mortality risk in NAFLD depends on the setting and method of ascertainment. Suspected NAFLD in the 45-54 age group is a strong independent risk factor for cardiovascular death and warrants further cardiovascular risk management guidelines.
病例系列研究表明,非酒精性脂肪性肝病(NAFLD)与全因死亡率和心血管死亡率升高相关。本研究比较了基于人群队列中疑似患有和未患有NAFLD的受试者的生存率,并将研究结果与先前发表的病例系列研究相结合。
主要分析使用国家死亡指数评估了美国国家健康和营养检查调查(NHANES)-III中疑似患有和未患有NAFLD的参与者的死亡率。疑似NAFLD基于无法解释的谷丙转氨酶(ALT)升高。还使用奥姆斯特德县和克利夫兰诊所的病例系列进行比较。使用比例风险模型和直接年龄标准化比较生存率。
NHANES队列包括980名疑似患有NAFLD的受试者和6594名未患该病的受试者。在平均8.7年的时间里,疑似NAFLD的全因死亡率风险比为1.37(95%可信区间0.98-1.91)。在45-54岁年龄组中,在调整传统心血管危险因素后,疑似NAFLD的全因死亡率(4.40,95%可信区间1.27-13.23)和心血管死亡率(8.15,95%可信区间2.00-33.20)显著更高。NHANES非NAFLD队列的年龄标准化死亡率为每年每10000人129例(95%可信区间118-140),NHANES疑似NAFLD队列的为154例(95%可信区间116-198),奥姆斯特德县系列的为214例(95%可信区间157-279),克利夫兰诊所系列的为426例(95%可信区间298-573)。
NAFLD的死亡风险程度取决于确定方法和研究背景。45-54岁年龄组中的疑似NAFLD是心血管死亡的一个强有力的独立危险因素,值得进一步制定心血管风险管理指南。